Marcel's questions to Recursion Pharmaceuticals Inc (RXRX) leadership • Q2 2024
Question
Marcel asked about the company's efforts in preventative healthcare, specifically developing drugs or partnerships to reduce the risk of diseases like cancer or Alzheimer's.
Answer
CEO Christopher Gibson confirmed that preventative medicine is a core part of Recursion's vision, highlighting existing pipeline programs that target genetic predispositions to cancer. He pointed to the Roche-Genentech collaboration as a key effort in neurodegeneration. Gibson emphasized that the company's foundational belief is that its technology can map and understand biological complexity at a scale necessary to tackle the multifaceted nature of preventative medicine.